Last reviewed · How we verify
BPT567
At a glance
| Generic name | BPT567 |
|---|---|
| Sponsor | Bright Peak Therapeutics Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BPT567 CI brief — competitive landscape report
- BPT567 updates RSS · CI watch RSS
- Bright Peak Therapeutics Inc portfolio CI